PRELIMINARY AGENDA
Timing: The first session will start at around 8:15 am on Tuesday, Nov 12 and the last session will end at approx. 3:30 pm on Thursday, Nov 14 at the latest.
Notes: Actual session order and talks as well as chosen submitted abstracts will be announced later. There will also be two dedicated poster sessions presenting posters, with new companies and selected posters presenting flash talks prior to poster sessions
Evening Events:
November 11: Welcome Networking Evening Event in Boston, 5:30 – 7:30 pm at Davios Northern Italian Steakhouse: 75 Arlington St, Boston
November 12: Dinner at the Hilton Boston Park Plaza at 7:30 pm
| Tue, Nov 12 – 08:15 am – 07:00 pm |
| Opening Remarks & Logistics |
| Introductory Session |
| RNA Basics |
| Keynote I – Drew Weissmann – Nucleoside-Modified mRNA-LNP Therapeutics |
| Vaccines & Antimicrobials |
| Flash Talks |
| Poster Session I |
| Wed, Nov 13 – 08:30 am – 06:00 pm |
| Keynote II – Peter Marks – The Expanding Promise of mRNA Technology |
| Delivery |
| Cancer Vaccines / Therapeutics I |
| Delivery / Manufacturing I |
| Poster Session II |
| Thu, Nov 14 – 08:30 am – 03:30 pm |
| Vaccines II |
| Delivery / Manufacturing II |
| Cancer Vaccines / Therapeutics II |
| Closing Remarks |
Already finalized session topics:
- Keynote Lecture
- mRNA Engineering and Translation
- Prophylactic Vaccines
- Delivery
- Cancer Vaccines and Therapeutics
- Therapeutics
- Manufacturing
